albuterol has been researched along with Breathing Sounds in 142 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the effect of albuterol spray on hypoxia and bronchospasm in patients with COPD under general anesthesia." | 9.69 | The Effect of Albuterol Spray on Hypoxia and Bronchospasm in Patients with Chronic Obstructive Pulmonary Disease (COPD) under General Anesthesia: A bouble-Blind Randomized Clinical Trial. ( Barzegari, A; Maddah, SA, 2023) |
| "Nebulized albuterol therapy does not appear to enhance recovery or attenuate severity of illness in infants hospitalized with acute, moderate bronchiolitis, as evidenced by improvement in oxygen saturation, time to meet standardized discharge criteria, or length of hospital stay." | 9.08 | The use of albuterol in hospitalized infants with bronchiolitis. ( Bay, C; Brallier, SL; Dobson, JV; McMahon, SR; Stemmler, MM; Stephens-Groff, SM, 1998) |
| "The benefits of metered-dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations." | 9.05 | Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta-analysis. ( Barrios-Sanjuanelo, A; Contreras-Arrieta, S; Florez-García, V; Payares-Salamanca, L; Rodriguez-Martinez, CE; Stand-Niño, I, 2020) |
| "Air-flow standardized breath sounds were recorded at the chest and at the trachea during histamine challenge test and after subsequent bronchodilation in 12 asthmatics and 6 healthy controls for spectral analysis, to be compared with simultaneous changes in spirometric variables." | 7.69 | Changes in frequency spectra of breath sounds during histamine challenge test in adult asthmatics and healthy control subjects. ( Haahtela, T; Katila, T; Malmberg, LP; Paajanen, E; Piirilä, P; Sovijärvi, AR, 1994) |
| " The aim of this study was to evaluate the effect of albuterol spray on hypoxia and bronchospasm in patients with COPD under general anesthesia." | 5.69 | The Effect of Albuterol Spray on Hypoxia and Bronchospasm in Patients with Chronic Obstructive Pulmonary Disease (COPD) under General Anesthesia: A bouble-Blind Randomized Clinical Trial. ( Barzegari, A; Maddah, SA, 2023) |
| " Study participants were randomly allocated to receive 1 of 3 treatments: once-daily tiotropium bromide 5 µg for 7 to 14 days during respiratory tract infections and as-needed albuterol sulfate 0." | 5.51 | Intermittent Tiotropium Bromide for Episodic Wheezing: A Randomized Trial. ( Aito, H; Jauhola, O; Klemola, T; Koponen, P; Kotaniemi-Syrjänen, A; Mäkelä, MJ; Malmberg, LP; Malmström, K; Pelkonen, AS; Rahiala, E; Sarna, S, 2022) |
| "Although bronchiolitis is a common reason for infant hospitalization, significant heterogeneity persists in its management." | 5.48 | Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis. ( Camargo, CA; Condella, A; Dayan, PS; Espinola, JA; Hasegawa, K; Mansbach, JM; Sullivan, AF, 2018) |
| "Magnesium sulfate has been shown to be an effective treatment in older children with asthma exacerbations, but it has not been investigated in acute severe virus-induced wheezing in young children." | 5.27 | Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial. ( Dunder, T; Kallio, M; Pokka, T; Pruikkonen, H; Renko, M; Tapiainen, T; Uhari, M, 2018) |
| "To compare the efficacy of a long-term treatment with Fluticasone Propionate administered by an MDI through both type of spacers, with and without valves, in young children with recurrent wheezing and risk factors for asthma." | 5.27 | Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma. ( Kofman, C; Teper, A, 2018) |
| "Our objective was to evaluate the efficacy and safety of two doses of fluticasone propionate (FP) in young children with recurrent wheezing and risk factors for asthma." | 5.11 | Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. ( Bergadá, I; Colom, AJ; Kofman, CD; Maffey, AF; Teper, AM; Vidaurreta, SM, 2004) |
| "Nebulized albuterol therapy does not appear to enhance recovery or attenuate severity of illness in infants hospitalized with acute, moderate bronchiolitis, as evidenced by improvement in oxygen saturation, time to meet standardized discharge criteria, or length of hospital stay." | 5.08 | The use of albuterol in hospitalized infants with bronchiolitis. ( Bay, C; Brallier, SL; Dobson, JV; McMahon, SR; Stemmler, MM; Stephens-Groff, SM, 1998) |
| "Nine young asthmatic children aged 2-5 years underwent methacholine challenge after placebo or albuterol administered by metered dose inhaler through a spacer device (Babyhaler) with a face mask in a double-blind, cross-over, randomized study." | 5.07 | Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children. ( Avital, A; Godfrey, S; Schachter, J; Springer, C, 1994) |
| "To test whether nebulized salbutamol (albuterol) is safe and efficacious for the treatment of young children with acute bronchiolitis, we enrolled 83 children (median age 6 months, range 1 to 21 months) in a randomized, double-blind clinical trial." | 5.07 | Randomized trial of salbutamol in acute bronchiolitis. ( Klassen, TP; Li, MM; McDowell, IW; Ropp, LJ; Rowe, PC; Sutcliffe, T, 1991) |
| "The benefits of metered-dose inhalers with a spacer (MDI+S) have increasingly been recognized as an alternative method of albuterol administration for treating pediatric asthma exacerbations." | 5.05 | Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta-analysis. ( Barrios-Sanjuanelo, A; Contreras-Arrieta, S; Florez-García, V; Payares-Salamanca, L; Rodriguez-Martinez, CE; Stand-Niño, I, 2020) |
| "Air-flow standardized breath sounds were recorded at the chest and at the trachea during histamine challenge test and after subsequent bronchodilation in 12 asthmatics and 6 healthy controls for spectral analysis, to be compared with simultaneous changes in spirometric variables." | 3.69 | Changes in frequency spectra of breath sounds during histamine challenge test in adult asthmatics and healthy control subjects. ( Haahtela, T; Katila, T; Malmberg, LP; Paajanen, E; Piirilä, P; Sovijärvi, AR, 1994) |
| "Respirosonography was used to analyze lung sounds and breathing patterns in 16 infants with acute bronchiolitis who were treated with nebulized salbutamol (albuterol)." | 3.68 | Respirosonography in infants with acute bronchiolitis. ( Pasterkamp, H; Sanchez, I; Tal, A, 1991) |
| " We will measure urinary salbutamol levels 30 min after dosing as an estimate of salbutamol doses in the lungs, and also look for genetic polymorphisms linked to poor responses to inhaled salbutamol." | 2.82 | How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? Study protocol for a randomised controlled trial. ( Alberti, C; Beydon, N; Bremner, S; Earl, G; Lansley, A; Mukhopadhyay, S; Olden, C; Palmer, CN; Seddon, P; Symes, L; Wileman, E, 2016) |
| "The additional use of an SABA by COPD patients improved their pulmonary function, which was accompanied by changes in regional lung air flow." | 2.79 | Effects of bronchodilators on regional lung sound distribution in patients with chronic obstructive pulmonary disease. ( Matsuoka, S; Mineshita, M; Miyazawa, T, 2014) |
| "Overall, adverse events occurred in 4 (9%) and 3 (7%) subjects in the 180-microg and 360-microg groups, respectively." | 2.75 | Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. ( Davis, AM; Ellsworth, A; Goodman, B; Kaashmiri, M; Lincourt, WR; Shepard, J; Trivedi, R, 2010) |
| "Significant cough is the most reliable antecedent of wheezing during an RTI." | 2.74 | Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing. ( Bacharier, LB; Camera, LJ; Chinchilli, VM; Paul, IM; Phillips, BR; Rivera-Spoljaric, K; Strunk, RC; Taussig, LM; Zeiger, RS, 2009) |
| "Satisfactory lung sounds recording and analysis was achieved in all subjects." | 2.73 | Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. ( Beck, R; Bentur, L; Elias, N; Godfrey, S; Shoval, S; Talmon, G; Tov, N, 2007) |
| " As opposed to data from an adult population, no plateau was reached in the dose-response curve using the above doses over time." | 2.69 | Is nebulized aerosol treatment necessary in the pediatric emergency department? ( Gilad, E; Houri, S; Mandelberg, A; Morag, B; Priel, IE; Tsehori, S, 2000) |
| " Ratios of PCwheeze between treatment and placebo challenges were calculated for each dosage group." | 2.69 | The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study. ( Brown, R; Efthimiou, J; Kurian, M; Primhak, RA; Smith, CM; Wach, R; Yong, SC, 1999) |
| "Albuterol was administered through the spacer device (50 microg/kg) or through the nebulizer (150 microg/kg) and repeated 3 times at 20-minute intervals." | 2.69 | High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: A double-blind, randomized equivalence trial. ( Chapuis, FR; Chatelain, PG; David, L; Dutau, G; Floret, D; Ploin, D; Robert, J; Stamm, D, 2000) |
| "Pretreatment with albuterol attenuated both the cough and the drop in FEV1." | 2.66 | Cough and wheezing from beclomethasone aerosol. ( Shim, C; Williams, MH, 1987) |
| "Key Words: Pulmonary alveolar proteinosis, Child, Atopy, Wheezing." | 1.72 | First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation. ( Avci, A; Kiyan, G; Ozcan, D; Sasihuseyinoglu, AS, 2022) |
| "Our aim was to survey treatment practices used for preschool children with wheezing in emergency rooms (ER) focussing on inhalation device choice and handling, face mask use, salbutamol dosing and written instructions." | 1.62 | Heterogeneity of emergency treatment practices in wheezing preschool children. ( Csonka, P; Lehtimäki, L; Mäkelä, MJ; Tapiainen, T, 2021) |
| "Although bronchiolitis is a common reason for infant hospitalization, significant heterogeneity persists in its management." | 1.48 | Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis. ( Camargo, CA; Condella, A; Dayan, PS; Espinola, JA; Hasegawa, K; Mansbach, JM; Sullivan, AF, 2018) |
| "Wheezing is common in preschool children, but objective evidence for airway obstruction and its reversibility are rarely available in clinical practice." | 1.36 | Lung function in preschool children with a history of wheezing measured by forced oscillation and plethysmographic specific airway resistance. ( Gibson, AM; Harrison, J; Johnson, K; Ranganathan, S; Singh, G; Skoric, B, 2010) |
| "Wheezing was the most common mentioned symptoms in taking asthma into consideration." | 1.35 | A survey of pediatricians' knowledge on asthma management in children. ( Abdollahpour, H; Bemanian, MH; Gharagozlou, M; Moinfar, Z; Sedaghat, M, 2008) |
| "Prevalence of wheezing is increasing, bronchodilators are sub-optimally utilized and antibiotics are over-prescribed." | 1.35 | Are we adequately managing children with wheeze using the standard case management guidelines? ( Bunnag, T; Jatanachai, P; Lochindarat, S; Nisar, YB; Qazi, SA, 2008) |
| "Lung sounds were measured in nine patients with asthma and five control subjects, alongside air flow measurements of forced expiratory volume (FEV1) and forced vital capacity (FVC)." | 1.31 | Limitations in the use of median frequency for lung sound analysis. ( Anderson, K; Carter, R; Lucas, M; Whittaker, AR, 2000) |
| "Childhood pneumonia is associated with reduced ventilatory function in adults." | 1.30 | Effect of pneumonia and whooping cough in childhood on adult lung function. ( Anderson, HR; Johnston, ID; Strachan, DP, 1998) |
| "Albuterol was effective in increasing the PEFR in patients with asthma, COPD and NANC." | 1.28 | The prehospital use of nebulized albuterol on patients with wheezing whose chief complaint is shortness of breath. ( Dickinson, ET; Megargel, R; O'Connor, RE, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (6.34) | 18.7374 |
| 1990's | 38 (26.76) | 18.2507 |
| 2000's | 48 (33.80) | 29.6817 |
| 2010's | 35 (24.65) | 24.3611 |
| 2020's | 12 (8.45) | 2.80 |
| Authors | Studies |
|---|---|
| Kotaniemi-Syrjänen, A | 2 |
| Klemola, T | 2 |
| Koponen, P | 1 |
| Jauhola, O | 1 |
| Aito, H | 1 |
| Malmström, K | 1 |
| Malmberg, LP | 3 |
| Rahiala, E | 1 |
| Sarna, S | 1 |
| Pelkonen, AS | 2 |
| Mäkelä, MJ | 3 |
| Sasihuseyinoglu, AS | 1 |
| Ozcan, D | 1 |
| Avci, A | 1 |
| Kiyan, G | 1 |
| Rajashekar, C | 1 |
| Shankar, NCG | 1 |
| S, A | 1 |
| Sharada, RC | 1 |
| Nedunchelian, K | 1 |
| Maddah, SA | 1 |
| Barzegari, A | 1 |
| Ramgopal, S | 1 |
| Mazzarini, A | 1 |
| Martin-Gill, C | 1 |
| Owusu-Ansah, S | 1 |
| Wall, MA | 1 |
| Vempilly, JJ | 1 |
| Abejie, BA | 1 |
| Rashidian, A | 1 |
| Jain, VV | 1 |
| Bhakta, N | 1 |
| Suárez-Medina, R | 1 |
| Venero-Fernández, S | 1 |
| Alvarez-Valdés, V | 1 |
| Sardiñas-Baez, N | 1 |
| Cristina, C | 1 |
| Loinaz-Gonzalez, M | 1 |
| Verdecia-Pérez, Z | 1 |
| Corona-Tamayo, B | 1 |
| Betancourt-López, M | 1 |
| Britton, J | 1 |
| Fogarty, AW | 1 |
| Paluch, L | 1 |
| Payares-Salamanca, L | 1 |
| Contreras-Arrieta, S | 1 |
| Florez-García, V | 1 |
| Barrios-Sanjuanelo, A | 1 |
| Stand-Niño, I | 1 |
| Rodriguez-Martinez, CE | 1 |
| Csonka, P | 2 |
| Tapiainen, T | 2 |
| Lehtimäki, L | 1 |
| Hurme, P | 1 |
| Homil, K | 1 |
| Lehtinen, P | 1 |
| Turunen, R | 1 |
| Vahlberg, T | 1 |
| Vuorinen, T | 1 |
| Camargo, CA | 2 |
| Gern, JE | 1 |
| Jartti, T | 1 |
| Fischer, J | 1 |
| Ohmer, M | 1 |
| Petersen, M | 1 |
| Morjaria, JB | 1 |
| Rigby, AS | 1 |
| Morice, AH | 1 |
| Kanjanapradap, T | 1 |
| Deerojanawong, J | 4 |
| Sritippayawan, S | 2 |
| Prapphal, N | 4 |
| Pruikkonen, H | 1 |
| Kallio, M | 1 |
| Dunder, T | 1 |
| Pokka, T | 1 |
| Uhari, M | 1 |
| Renko, M | 1 |
| Condella, A | 1 |
| Mansbach, JM | 1 |
| Hasegawa, K | 1 |
| Dayan, PS | 1 |
| Sullivan, AF | 1 |
| Espinola, JA | 1 |
| Pizzulli, A | 1 |
| Perna, S | 1 |
| Bennewiz, A | 1 |
| Roeblitz, H | 1 |
| Tripodi, S | 1 |
| Florack, J | 1 |
| Wagner, P | 1 |
| Hofmaier, S | 1 |
| Matricardi, PM | 1 |
| Kofman, C | 1 |
| Teper, A | 1 |
| Currie, G | 1 |
| Crotts, J | 1 |
| Nettel-Aguirre, A | 1 |
| Johnson, D | 1 |
| Stang, A | 1 |
| Kozian, A | 1 |
| Schilling, T | 1 |
| Mineshita, M | 1 |
| Matsuoka, S | 1 |
| Miyazawa, T | 1 |
| Castro-Rodriguez, JA | 3 |
| Silva, R | 1 |
| Tapia, P | 1 |
| Salinas, P | 1 |
| Tellez, A | 1 |
| Leisewitz, T | 1 |
| Sanchez, I | 4 |
| Vilaro, J | 1 |
| Torres-Castro, R | 1 |
| Postiaux, G | 2 |
| Morris, I | 1 |
| Lyttle, MD | 1 |
| O'Sullivan, R | 1 |
| Sargant, N | 1 |
| Doull, IJ | 1 |
| Powell, CV | 1 |
| Blake, LK | 1 |
| Silverstone, E | 1 |
| Yates, DH | 1 |
| Czövek, D | 1 |
| Shackleton, C | 1 |
| Hantos, Z | 1 |
| Taylor, K | 1 |
| Kumar, A | 1 |
| Chacko, A | 1 |
| Ware, RS | 1 |
| Makan, G | 1 |
| Radics, B | 1 |
| Gingl, Z | 1 |
| Sly, PD | 3 |
| Lanza, FC | 1 |
| Wandalsen, GF | 1 |
| Dos Santos, AM | 1 |
| Solé, D | 1 |
| Mukhopadhyay, S | 1 |
| Seddon, P | 4 |
| Earl, G | 1 |
| Wileman, E | 1 |
| Symes, L | 1 |
| Olden, C | 1 |
| Alberti, C | 1 |
| Bremner, S | 1 |
| Lansley, A | 1 |
| Palmer, CN | 1 |
| Beydon, N | 1 |
| Razi, CH | 1 |
| Cörüt, N | 1 |
| Andıran, N | 1 |
| Gharagozlou, M | 1 |
| Abdollahpour, H | 1 |
| Moinfar, Z | 1 |
| Bemanian, MH | 1 |
| Sedaghat, M | 1 |
| Bacharier, LB | 2 |
| Phillips, BR | 2 |
| Zeiger, RS | 2 |
| Szefler, SJ | 1 |
| Martinez, FD | 2 |
| Lemanske, RF | 1 |
| Sorkness, CA | 1 |
| Bloomberg, GR | 1 |
| Morgan, WJ | 1 |
| Paul, IM | 2 |
| Guilbert, T | 1 |
| Krawiec, M | 1 |
| Covar, R | 1 |
| Larsen, G | 1 |
| Mellon, M | 1 |
| Moss, MH | 1 |
| Chinchilli, VM | 2 |
| Taussig, LM | 2 |
| Strunk, RC | 2 |
| Becker, AB | 1 |
| Panickar, J | 1 |
| Lakhanpaul, M | 1 |
| Lambert, PC | 1 |
| Kenia, P | 1 |
| Stephenson, T | 1 |
| Smyth, A | 1 |
| Grigg, J | 1 |
| Lochindarat, S | 1 |
| Qazi, SA | 1 |
| Bunnag, T | 1 |
| Nisar, YB | 1 |
| Jatanachai, P | 1 |
| Rivera-Spoljaric, K | 1 |
| Camera, LJ | 1 |
| Dieppe, C | 1 |
| Verma, S | 1 |
| Wilson, B | 1 |
| Koumbourlis, AC | 1 |
| Mroueh, S | 1 |
| Papi, A | 2 |
| Nicolini, G | 2 |
| Baraldi, E | 2 |
| Boner, AL | 2 |
| Cutrera, R | 2 |
| Rossi, GA | 2 |
| Fabbri, LM | 2 |
| Anil, AB | 1 |
| Anil, M | 1 |
| Saglam, AB | 1 |
| Cetin, N | 1 |
| Bal, A | 1 |
| Aksu, N | 1 |
| Kaashmiri, M | 1 |
| Shepard, J | 1 |
| Goodman, B | 1 |
| Lincourt, WR | 1 |
| Trivedi, R | 1 |
| Ellsworth, A | 1 |
| Davis, AM | 1 |
| Mele, L | 1 |
| Calogero, C | 1 |
| Bernardini, R | 1 |
| Novembre, E | 1 |
| Azzari, C | 1 |
| de Martino, M | 1 |
| Lombardi, E | 1 |
| Jerzynska, J | 1 |
| Stelmach, I | 1 |
| Grzelewski, T | 1 |
| Stelmach, W | 1 |
| Krakowiak, J | 1 |
| Harrison, J | 1 |
| Gibson, AM | 1 |
| Johnson, K | 1 |
| Singh, G | 1 |
| Skoric, B | 1 |
| Ranganathan, S | 1 |
| Louis, J | 1 |
| Labasse, HC | 1 |
| Gerroldt, J | 1 |
| Kotik, AC | 1 |
| Lemuhot, A | 1 |
| Patte, C | 1 |
| Mecklin, M | 2 |
| Paassilta, M | 2 |
| Kainulainen, H | 1 |
| Korppi, M | 3 |
| Maiello, N | 1 |
| Del Giudice, MM | 1 |
| Capristo, C | 1 |
| Decimo, F | 1 |
| Santaniello, F | 1 |
| Perrone, L | 1 |
| Boner, A | 1 |
| Debley, J | 1 |
| Stanojevic, S | 1 |
| Filbrun, AG | 1 |
| Subbarao, P | 1 |
| Jenkins, C | 1 |
| Seccombe, L | 1 |
| Tomlins, R | 1 |
| Ater, D | 1 |
| Shai, H | 1 |
| Bar, BE | 1 |
| Fireman, N | 1 |
| Tasher, D | 1 |
| Dalal, I | 1 |
| Ballin, A | 1 |
| Mandelberg, A | 2 |
| Kajosaari, M | 1 |
| Joshi, S | 1 |
| Powell, T | 1 |
| Watkins, WJ | 1 |
| Drayton, M | 1 |
| Williams, EM | 1 |
| Kotecha, S | 1 |
| Boskabady, M | 2 |
| Boskabady, MH | 1 |
| Zabihi, NA | 1 |
| Barrueto, L | 1 |
| Mallol, J | 1 |
| Figueroa, L | 1 |
| Chavasse, RJ | 3 |
| Bastian-Lee, Y | 2 |
| Delgado, A | 1 |
| Chou, KJ | 1 |
| Silver, EJ | 1 |
| Crain, EF | 1 |
| Kamps, AW | 1 |
| Brand, PL | 1 |
| Hofhuis, W | 1 |
| van der Wiel, EC | 1 |
| Tiddens, HA | 1 |
| Brinkhorst, G | 1 |
| Holland, WP | 1 |
| de Jongste, JC | 1 |
| Merkus, PJ | 1 |
| Chan, EY | 2 |
| Bridge, PD | 4 |
| Dundas, I | 2 |
| Pao, CS | 1 |
| Healy, MJ | 2 |
| McKenzie, SA | 4 |
| Pershad, J | 1 |
| Chin, T | 1 |
| Barbato, A | 1 |
| Panizzolo, C | 1 |
| Landi, L | 1 |
| Semenzato, R | 1 |
| Rugge, M | 1 |
| Teper, AM | 1 |
| Colom, AJ | 1 |
| Kofman, CD | 1 |
| Maffey, AF | 1 |
| Vidaurreta, SM | 1 |
| Bergadá, I | 1 |
| Beardsmore, CS | 1 |
| Page, C | 1 |
| Silverman, M | 4 |
| Hazir, T | 1 |
| Qazi, S | 1 |
| Bin Nisar, Y | 1 |
| Ansari, S | 1 |
| Maqbool, S | 1 |
| Randhawa, S | 1 |
| Kundi, Z | 1 |
| Asghar, R | 1 |
| Aslam, S | 1 |
| Manuyakorn, W | 1 |
| Harnruthakorn, C | 1 |
| Samransamruajkit, R | 1 |
| Futrakul, S | 1 |
| Cho, SH | 1 |
| Oh, SY | 1 |
| Bahn, JW | 1 |
| Choi, JY | 1 |
| Chang, YS | 1 |
| Kim, YK | 1 |
| Min, KU | 1 |
| Kim, YY | 1 |
| Hyvärinen, MK | 1 |
| Reijonen, TM | 1 |
| Korhonen, K | 1 |
| Kiviniemi, V | 1 |
| Egbagbe, EE | 1 |
| Elusoji, SO | 1 |
| Brockmann, P | 1 |
| Fodor, D | 1 |
| Caussade, S | 1 |
| Campos, E | 1 |
| Bertrand, P | 2 |
| Lehmann, S | 1 |
| Bakke, PS | 1 |
| Eide, GE | 1 |
| Gulsvik, A | 1 |
| Erzinger, S | 1 |
| Schueepp, KG | 1 |
| Brooks-Wildhaber, J | 1 |
| Devadason, SG | 2 |
| Wildhaber, JH | 3 |
| Beck, R | 1 |
| Elias, N | 1 |
| Shoval, S | 1 |
| Tov, N | 1 |
| Talmon, G | 1 |
| Godfrey, S | 2 |
| Bentur, L | 2 |
| Eigen, H | 1 |
| Montgomery, GS | 1 |
| Bohn, D | 1 |
| Tal, A | 2 |
| Bavilski, C | 1 |
| Yohai, D | 1 |
| Bearman, JE | 1 |
| Gorodischer, R | 1 |
| Moses, SW | 1 |
| Bangham, CR | 1 |
| Hope, RA | 1 |
| Lødrup Carlsen, KC | 1 |
| Halvorsen, R | 1 |
| Ahlstedt, S | 1 |
| Carlsen, KH | 1 |
| Campbell, IA | 1 |
| Colman, SB | 1 |
| Mao, JH | 1 |
| Prescott, RJ | 1 |
| Weston, CF | 1 |
| Carter, ER | 1 |
| Avital, A | 1 |
| Schachter, J | 1 |
| Springer, C | 1 |
| Hickey, RW | 1 |
| Gochman, RF | 1 |
| Chande, V | 1 |
| Davis, HW | 1 |
| Galoppin, L | 1 |
| de Blic, J | 1 |
| Azevedo, I | 1 |
| Scheinmann, P | 1 |
| Vargaftig, BB | 1 |
| Bachelet, M | 1 |
| Pikielny, R | 1 |
| Yuksel, B | 2 |
| Greenough, A | 2 |
| Sovijärvi, AR | 1 |
| Paajanen, E | 1 |
| Piirilä, P | 1 |
| Haahtela, T | 1 |
| Katila, T | 1 |
| Clough, JB | 1 |
| Fox, GF | 1 |
| Marsh, MJ | 1 |
| Milner, AD | 2 |
| Ohta, K | 1 |
| Nakagome, K | 1 |
| Akiyama, K | 1 |
| Sano, Y | 1 |
| Matsumura, Y | 1 |
| Kudo, S | 1 |
| Yamada, K | 1 |
| Mano, K | 1 |
| Kabe, J | 1 |
| Miyashita, H | 1 |
| Strachan, DP | 2 |
| Griffiths, JM | 1 |
| Johnston, ID | 2 |
| Anderson, HR | 2 |
| Hayden, MJ | 2 |
| Eber, E | 1 |
| Summers, QA | 1 |
| LeSouëf, PN | 2 |
| Kraemer, R | 3 |
| Graf Bigler, U | 1 |
| Casaulta Aebischer, C | 1 |
| Weder, M | 1 |
| Birrer, P | 1 |
| Klig, JE | 1 |
| Hodge, D | 1 |
| Rutherford, MW | 1 |
| Graves, PE | 1 |
| Baldini, M | 1 |
| Solomon, S | 1 |
| Erickson, R | 1 |
| Dobson, JV | 1 |
| Stephens-Groff, SM | 1 |
| McMahon, SR | 1 |
| Stemmler, MM | 1 |
| Brallier, SL | 1 |
| Bay, C | 1 |
| Edell, D | 2 |
| Bruce, E | 1 |
| Hale, K | 1 |
| Khoshoo, V | 1 |
| Dalphin, JC | 1 |
| Dubiez, A | 1 |
| Monnet, E | 1 |
| Gora, D | 1 |
| Westeel, V | 1 |
| Pernet, D | 1 |
| Polio, JC | 1 |
| Gibey, R | 1 |
| Laplante, JJ | 1 |
| Depierre, A | 1 |
| Jackson, AC | 1 |
| Tennhoff, W | 1 |
| Frey, U | 2 |
| Rubilar, L | 1 |
| Girardi, G | 1 |
| Milanese, M | 1 |
| Mondino, C | 1 |
| Tosca, M | 1 |
| Canonica, GW | 1 |
| Brusasco, V | 1 |
| Yamamoto, LG | 2 |
| Okamura, D | 1 |
| Nagamine, J | 1 |
| Boychuk, RB | 1 |
| Halm, B | 1 |
| Lee, E | 1 |
| Yee, LL | 1 |
| Richter, H | 1 |
| Hilliard, T | 1 |
| Tsehori, S | 1 |
| Houri, S | 1 |
| Gilad, E | 1 |
| Morag, B | 1 |
| Priel, IE | 1 |
| Primhak, RA | 1 |
| Smith, CM | 1 |
| Yong, SC | 1 |
| Wach, R | 1 |
| Kurian, M | 1 |
| Brown, R | 1 |
| Efthimiou, J | 1 |
| Whittaker, AR | 1 |
| Lucas, M | 1 |
| Carter, R | 1 |
| Anderson, K | 1 |
| Ploin, D | 1 |
| Chapuis, FR | 1 |
| Stamm, D | 1 |
| Robert, J | 1 |
| David, L | 1 |
| Chatelain, PG | 1 |
| Dutau, G | 1 |
| Floret, D | 1 |
| Casaburi, R | 1 |
| Briggs, DD | 1 |
| Donohue, JF | 1 |
| Serby, CW | 1 |
| Menjoge, SS | 1 |
| Witek, TJ | 1 |
| Araníbar, H | 1 |
| Castro, E | 1 |
| Rasul, CH | 1 |
| Khan, MA | 1 |
| Yuksel, H | 1 |
| Coskun, S | 1 |
| Polat, M | 1 |
| Onag, A | 1 |
| Mylonopoulou, M | 1 |
| Walsh-Kelly, CM | 1 |
| Hennes, HM | 1 |
| Wiebe, RA | 1 |
| Anaya, C | 1 |
| Chang, RK | 1 |
| Chang, MA | 1 |
| Terada, AM | 1 |
| Bray, ML | 1 |
| Ching, CY | 1 |
| Kim, MY | 1 |
| Shinsato, ET | 1 |
| Dickinson, ET | 1 |
| O'Connor, RE | 1 |
| Megargel, R | 1 |
| Schweich, PJ | 1 |
| Hurt, TL | 1 |
| Walkley, EI | 1 |
| Mullen, N | 1 |
| Archibald, LF | 1 |
| Pasterkamp, H | 1 |
| Garrett, JE | 1 |
| Turner, P | 1 |
| Canny, GJ | 1 |
| Shields, MD | 1 |
| Kerem, E | 1 |
| Schuh, S | 1 |
| Reisman, JJ | 1 |
| Fakhoury, K | 1 |
| Pedder, L | 1 |
| Levison, H | 1 |
| Orłowski, L | 1 |
| Zychowicz, C | 1 |
| Migdał, M | 1 |
| Gutkowski, P | 1 |
| Sommer, CW | 1 |
| Russi, E | 1 |
| Lanteri, CJ | 1 |
| Raven, JM | 1 |
| Klassen, TP | 1 |
| Rowe, PC | 1 |
| Sutcliffe, T | 1 |
| Ropp, LJ | 1 |
| McDowell, IW | 1 |
| Li, MM | 1 |
| Seidenberg, J | 1 |
| Mir, Y | 1 |
| von der Hardt, H | 1 |
| Taurand, P | 1 |
| Milner, A | 1 |
| Kinnear, G | 1 |
| Prendiville, A | 3 |
| Green, S | 2 |
| Rose, A | 1 |
| Maxwell, DL | 1 |
| Mussell, MJ | 1 |
| Hartley, JP | 1 |
| O'Callaghan, C | 1 |
| Swarbrick, A | 1 |
| Shim, C | 1 |
| Williams, MH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Intermittent Tiotropium in Early Childhood Wheezing[NCT03199976] | Phase 4 | 80 participants (Actual) | Interventional | 2016-04-20 | Completed | ||
| Viral Inception of Asthma: Prospective Study From Infancy to School-age.[NCT00731575] | 200 participants (Anticipated) | Interventional | 2007-06-30 | Active, not recruiting | |||
| [NCT00494624] | Phase 4 | 300 participants (Anticipated) | Interventional | 2000-09-30 | Recruiting | ||
| The Efficacy of Intravenous Magnesium in Acute Wheezy Bronchitis in Small Children - a Randomized, Controlled Study[NCT01383655] | 61 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| Study on Dose-response to Bronchodilator Then Bronchodilator Dose-finding Using the Flow Interruption Technique in Children Aged 2.5 TO 6 Years[NCT01470755] | Phase 2 | 90 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
| [NCT00272441] | 0 participants | Interventional | 2001-01-31 | Completed | |||
| Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)[NCT00319488] | 238 participants (Actual) | Interventional | 2004-02-29 | Completed | |||
| Double Blind, Multinational, Multicentre, Parallel-group, Placebo-controlled Design Trial of the Efficacy and Safety of Nebulised Beclometahsone Dipropionate (400 μg b.i.d.) Plus as Needed Salbutamol Versus as Needed Salbutamol or as Needed Salbutamol/Bec[NCT00497523] | Phase 3 | 283 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| Study of the Effect of Inhaled 3% Hypertonic Saline Compared With Normal Saline (0,9%) for the Treatment of Acute Viral Bronchiolitis in a Short Stay Ward[NCT02045238] | 32 participants (Actual) | Interventional | 2013-07-31 | Terminated (stopped due to Technical difficulties (reduced staff plus university strike)) | |||
| A Randomized Trial of Nebulized 3% Hypertonic Saline With Salbutamol in the Treatment of Acute Bronchiolitis in Pediatric Hospital[NCT02233985] | Phase 4 | 64 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| "FIBARRIX Clinical Evaluation of the Response to Chest Physiotherapy in Infants With Acute Bronchiolitis"[NCT02458300] | 77 participants (Actual) | Interventional | 2015-01-31 | Completed | |||
| Multicenter Randomized Controlled Trial: Evaluation of the Effects of Respiratory Physiotherapy, Placebo-controlled, in Infants With Moderate Acute Bronchiolitis[NCT03753802] | 168 participants (Anticipated) | Interventional | 2019-12-01 | Recruiting | |||
| "Interventional Study: Hypertonic Saline as Add on Treatment to the Usual Therapy for Preschool Children With Acute Asthmatic Attack Presenting to the ER: A Double Blind Control Study"[NCT01073527] | 41 participants (Actual) | Interventional | 2009-01-31 | Completed | |||
| A Prospective Observational Study in a Tertiary Pediatric Hospital in Beijing to Understand the Accuracy of Bronchodilator Response (BDR) in Chinese Controller Naive Asthmatic Children Between the Age of 4~12 Years Old[NCT01500525] | 587 participants (Actual) | Observational | 2011-12-31 | Completed | |||
| The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial[NCT02914652] | Phase 4 | 96 participants (Actual) | Interventional | 2016-10-15 | Completed | ||
| Adiposity and Airway Inflammation in HIV-Associated Airway Disease[NCT02975258] | 102 participants (Actual) | Observational | 2015-09-30 | Completed | |||
| Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study[NCT00361452] | Phase 4 | 30 participants | Interventional | 2000-12-31 | Terminated | ||
| Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.[NCT03436225] | Phase 1 | 80 participants (Anticipated) | Interventional | 2019-02-28 | Not yet recruiting | ||
| Oral Dexamethasone Versus Oral Prednisone in Children Hospitalized With Asthma: A Randomized Control Study[NCT02780479] | Phase 4 | 6 participants (Actual) | Interventional | 2017-03-20 | Terminated (stopped due to insufficient number of participants met the enrollment criteria.) | ||
| [NCT00005475] | 0 participants | Observational | 1996-08-31 | Completed | |||
| Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge[NCT03926741] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2019-04-30 | Recruiting | ||
| "Are Steroids Efficacious in Hospitalized Patients With Bronchiolitis Who Show an Objective Clinical Improvement After Albuterol (Albuterol Responders)?"[NCT00798616] | 0 participants (Actual) | Interventional | Withdrawn (stopped due to We were unable to enroll a sufficient number of patients due to manpower.) | ||||
| A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers[NCT02777125] | 980 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| Effectiveness of Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Acute Asthma in Children in Suez Canal University Hospital Emergency Department: A Randomized Control Trial[NCT03816267] | Phase 3 | 60 participants (Actual) | Interventional | 2018-05-15 | Completed | ||
| Effectiveness and Costs of Albuterol Delivered by MDI With Spacer Versus Nebulizer in Children Hospitalized With Moderate and Severe Asthma Exacerbations[NCT00623688] | 11 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma[NCT02566902] | 118 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn[NCT05006235] | Phase 1 | 135 participants (Actual) | Interventional | 2014-02-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Any adverse effects directly attributable to treatment shall be noted. Mere lack of improve or worsening of symptoms attributable to the disease clinical course will not be considered as adverse effects. (NCT02045238)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Normal Saline | 0 |
| Hypertonic Saline | 0 |
Patients staying longer than 24h are considered to be admitted to ward. (NCT02045238)
Timeframe: 24 hours
| Intervention | participants (Number) |
|---|---|
| Normal Saline | 3 |
| Hypertonic Saline | 6 |
Each patient record the time of entry and measured the total hospital stay time in hours, recording the time of discharge to determine the total stay in hours. The hospital stay will be evaluated in hours. Staying hospitalized until they had mild respiratory stage scale scores for at least 2 hrs. (NCT02233985)
Timeframe: Throughout the stay for each patient until discharge. Follow-up will be continued for a period of 30 days in which they may present readmissions, complications or adverse effects.
| Intervention | hours (Median) |
|---|---|
| Hypertonic Saline Solution 3% (SHS 3%) | 8 |
| Saline Solution 0.9% (SS 0.9%) Group | 39.3 |
It is a validated clinical scale, sufficiently reliable measure of Severity of the respiratory distress. It consists of the summation score of the sibilance / crackling parameters (the largest of them), respiratory effort, pulmonary air inlet, oxygen saturation, heart rate and breathing rate. It is stratified into 3 levels of severity: mild from 0 to 5 points, moderate from 6 to 10 and severe from 10 to 16. (NCT02233985)
Timeframe: Basal, 30 minutes after the end of the first 3 continuous nebulization sessions, at 4 hours, 8 hours and every 24 hours during the entire hospital stay
| Intervention | units on a scale (Median) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basal | 30 minutes | 4 hours | 8 hours | 12 hours | 24 hours | 48 hours | 72 hours | 96 hours | 120 hours | 144 hours | 196 hours | |
| Hypertonic Saline Solution 3% (HSS 3%) Group | 8 | 6 | 5 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Saline Solution 0.9% (SS 0.9%) Group | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 5 | 3 | 6 | 4 |
"To observe bronchodilator response(BDR) distribution curve for Chinese non-asthmatic children from 4-12 years, BDR calculated as: (FEV 1 L post-bronchodilator - FEV 1 L pre-bronchodilator)/FEV 1 L pre-bronchodilator × 100%.~To observe BDR distribution curve for Chinese controller-naïve asthmatic children from 4-12 years~To compare BDR values between non-asthmatic group and controller-naïve asthmatic group, and analyze appropriate cut-off point value" (NCT01500525)
Timeframe: 3 years
| Intervention | percentage of BDR (Mean) |
|---|---|
| Asthmatic Children | 9.45 |
| Non-asthmatic Children | 3.30 |
Patient disposition is measured as subjects requiring further treatment and being admitted to hospital. We record the number of patients in each cohort that required admission to the hospital after being evaluated and treated in the Emergency Department. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants admitted to the Hospital (Number) |
|---|---|
| Albuterol by Metered Dose Inhaler | 53 |
| Albuterol Breath Actuated Nebulizer | 57 |
Defined as a repeat visit to the Emergency Department for a complaint related to their wheezing, within 7 days of initial enrollment in the study. (NCT02777125)
Timeframe: Within 7 days of initial presentation
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 5 |
| Albuterol Breath Actuated Nebulizer | 4 |
Defined as a patient needing ondansetron for symptomatic relief of their nausea after initiating therapy in the Emergency Department. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 14 |
| Albuterol Breath Actuated Nebulizer | 18 |
Defined as anytime after initiation of therapy when the patient's heart rate exceeded age adjusted normal sinus rhythm heart rates for their age. Not uncommonly, patient's experience tachycardia as an unintended side effect of receiving albuterol. Tachycardia can result in a patient requiring further observation in the Emergency department and therefore increasing Emergency Department length of stay. We want to determine if indeed tachycardia is unavoidable, or if its presence suggests that patients are receiving too much albuterol or if albuterol is being given by the wrong appliance. (NCT02777125)
Timeframe: 6 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Albuterol by Metered Dose Inhaler | 101 |
| Albuterol Breath Actuated Nebulizer | 141 |
Emergency department length of stay is defined as the point of time when the patient checked into the Emergency Department to the time of final disposition. (NCT02777125)
Timeframe: 6 hours
| Intervention | minutes (Mean) | |
|---|---|---|
| Mild severity | Moderate severity | |
| Albuterol Breath Actuated Nebulizer | 197 | 245 |
| Albuterol by Metered Dose Inhaler | 192 | 232 |
Pre-treatment spirometry measurement assessed at the time of study enrollment. Post-treatment spirometry measurement assessed following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in FEV1 calculated as post-treatment FEV1 minus pre-treatment FEV1 (NCT02566902)
Timeframe: 10 minutes
| Intervention | %predicted (Mean) |
|---|---|
| T-piece Nebulizer | 13.8 |
| Breath-Enhanced Nebulizer | 9.1 |
"Blinded research personnel will assess subject's heart rate by auscultation and/or pulse palpation prior to and immediately following albuterol administration.~Pre-treatment assessment at the time of study enrollment. Post-treatment assessment following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in heart rate calculated as post-treatment heart rate minus pre-treatment heart rate." (NCT02566902)
Timeframe: 10 minutes
| Intervention | beats per minute (Mean) |
|---|---|
| T-piece Nebulizer | 4.34 |
| Breath-Enhanced Nebulizer | 15.05 |
"Based on examination and auscultation of lungs prior to and immediately following albuterol administration.~PAS score is on a scale of 0-10 which is a sum of five separate sub-scores each on a scale of 0-2. The five sub-scores are:~Respiratory rate (6-12yr/>12yr): <=26/23 (0), 27-30/24-27 (1), >31/28 (2)~Oxygenation: >95% (0), 90-95 (1), <90 (2)~Auscultation: clear/end expiratory wheeze (0), expiratory wheeze (1), biphasic wheeze/diminished (2)~Work of Breathing (accessory muscles): <= 1 (0), 2 (1), >=3 (2)~Dyspnea: Full sentences (0), Partial sentences (1), Single words (2)~Pre-treatment assessment at the time of study enrollment. Post-treatment assessment following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in PAS calculated as post-treatment PAS minus pre-treatment PAS." (NCT02566902)
Timeframe: 10 minutes
| Intervention | score on a scale (Median) |
|---|---|
| T-piece Nebulizer | -1 |
| Breath-Enhanced Nebulizer | -2 |
"Determined by examination and auscultation of lungs to prior to and immediately following albuterol administration.~PASS is a total score on a scale of 0-6 which is calculated as a sum of three sub-scores, each on a scale of 0-2. The sub-scores are:~Wheezing: None or Mild (0), Moderate (1), Severe wheezing or absent wheezing due to poor air exchange (2)~Work of breathing (accessory muscle use or retractions): None or mild (0), Moderate (1), Severe (2)~Prolonged expiration: Normal or mildly prolonged (0), moderately prolonged (1), severely prolonged (2)~Pre-treatment assessment at the time of study enrollment. Post-treatment assessment following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in PASS calculated as post-treatment PASS minus pre-treatment PASS." (NCT02566902)
Timeframe: 10 minutes
| Intervention | score on a scale (Median) |
|---|---|
| T-piece Nebulizer | -1 |
| Breath-Enhanced Nebulizer | -1 |
"Respiratory rate will be measured by observation and auscultation over 30 seconds prior to and immediately following albuterol administration~Pre-treatment assessment at the time of study enrollment. Post-treatment assessment following the administration of one time 5mg nebulized albuterol sulfate treatment. Assessments taken at baseline (prior to albuterol therapy) and 10 min post-treatment. Change in respiratory rate calculated as post-treatment respiratory rate minus pre-treatment respiratory rate." (NCT02566902)
Timeframe: 10 minutes
| Intervention | breaths/min (Mean) |
|---|---|
| T-piece Nebulizer | -3.1 |
| Breath-Enhanced Nebulizer | -3.2 |
Total length of stay will be assessed at the time of Emergency Department disposition which will be approximately 3 hours, but will be assessed up to 24 hours depending on duration of ED stay. (NCT02566902)
Timeframe: Up to 24 hours
| Intervention | minutes (Mean) |
|---|---|
| T-piece Nebulizer | 246.3 |
| Breath-Enhanced Nebulizer | 246.2 |
"Subjects and parents/guardians will be asked whether subjects experienced nausea, vomiting, palpitations, headache, dizziness either during (assessed by non-blinded personnel) or following treatment (assessed by blinded personnel during post-treatment assessment). Subject and parent/guardian will also be asked if any other side effects were experienced." (NCT02566902)
Timeframe: 10 minutes
| Intervention | Participants (Count of Participants) |
|---|---|
| T-piece Nebulizer | 5 |
| Breath-Enhanced Nebulizer | 5 |
Admission rate to inpatient hospital will be assessed at the time of Emergency Department disposition which will be approximately 3 hours, but will be assessed up to 24 hours depending on duration of ED stay. (NCT02566902)
Timeframe: Up to 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| T-piece Nebulizer | 11 |
| Breath-Enhanced Nebulizer | 11 |
Cumulative dose of albuterol in mg will be assessed at the time of Emergency Department disposition which will be approximately 3 hours, but will be assessed up to 24 hours depending on duration of ED stay. (NCT02566902)
Timeframe: up to 24 hours
| Intervention | mg (Mean) |
|---|---|
| T-piece Nebulizer | 18.2 |
| Breath-Enhanced Nebulizer | 18.7 |
4 reviews available for albuterol and Breathing Sounds
| Article | Year |
|---|---|
Bronchodilators and steroids should not be given in viral bronchiolitis - CON.
Topics: Adrenal Cortex Hormones; Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Child; Child, Presc | 2019 |
Identifying and managing bronchiolitis.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Age Factors; Albuterol; Bronchiolitis, Viral; F | 2020 |
Metered-dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta-analysis.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Child; Disease | 2020 |
[Asthmatic attack].
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Middle Aged; Respiratory Sounds | 2018 |
59 trials available for albuterol and Breathing Sounds
| Article | Year |
|---|---|
Intermittent Tiotropium Bromide for Episodic Wheezing: A Randomized Trial.
Topics: Albuterol; Bronchodilator Agents; Child; Child, Preschool; Double-Blind Method; Dyspnea; Fluticasone | 2022 |
The Effect of Albuterol Spray on Hypoxia and Bronchospasm in Patients with Chronic Obstructive Pulmonary Disease (COPD) under General Anesthesia: A bouble-Blind Randomized Clinical Trial.
Topics: Adult; Albuterol; Anesthesia, General; Bronchial Spasm; Bronchodilator Agents; Cough; Double-Blind M | 2023 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Age Distribution; Aged; Albuterol; Anti-Asthmatic Agents | 2017 |
Does nebulized hypertonic saline shorten hospitalization in young children with acute viral wheezing?
Topics: Administration, Inhalation; Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Child, Preschool | 2018 |
Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial.
Topics: Acute Disease; Administration, Intravenous; Albuterol; Asthma; Bronchodilator Agents; Child, Prescho | 2018 |
Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma.
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Fluticasone; Humans; Infant; Inhalation Spacers; M | 2018 |
Management of Wheezy Preschoolers in the Emergency Department: A Discrete Choice Experiment.
Topics: Adrenal Cortex Hormones; Albuterol; Canada; Child; Child, Preschool; Emergency Service, Hospital; Hu | 2021 |
Effects of bronchodilators on regional lung sound distribution in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind M | 2014 |
Chest physiotherapy is not clinically indicated for infants receiving outpatient care for acute wheezing episodes.
Topics: Acute Disease; Albuterol; Ambulatory Care; Bronchodilator Agents; Female; Humans; Infant; Logistic M | 2014 |
How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? Study protocol for a randomised controlled trial.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Child; Child, Preschool; | 2016 |
Budesonide reduces hospital admission rates in preschool children with acute wheezing.
Topics: Acute Disease; Albuterol; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Double-Blind M | 2017 |
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
Topics: Acetates; Administration, Inhalation; Albuterol; Bronchodilator Agents; Budesonide; Child, Preschool | 2008 |
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
Topics: Acetates; Administration, Inhalation; Albuterol; Bronchodilator Agents; Budesonide; Child, Preschool | 2008 |
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
Topics: Acetates; Administration, Inhalation; Albuterol; Bronchodilator Agents; Budesonide; Child, Preschool | 2008 |
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.
Topics: Acetates; Administration, Inhalation; Albuterol; Bronchodilator Agents; Budesonide; Child, Preschool | 2008 |
Oral prednisolone for preschool children with acute virus-induced wheezing.
Topics: Acute Disease; Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Preschool; Doub | 2009 |
Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing.
Topics: Acetates; Adult; Albuterol; Anti-Asthmatic Agents; Asthenia; Bronchodilator Agents; Budesonide; Caus | 2009 |
Regular vs prn nebulized treatment in wheeze preschool children.
Topics: Administration, Inhalation; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator | 2009 |
High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis.
Topics: Administration, Inhalation; Albuterol; Analysis of Variance; Bronchiolitis; Bronchodilator Agents; C | 2010 |
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Dose-Response Relationship, | 2010 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis.
Topics: Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Female; Heart Rate; Humans; Infant; Male; Ne | 2011 |
Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school children.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Anti-Asthmatic Agents; Asthma; Beclo | 2011 |
Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Female; Humans; Infant; Male; Prevalence | 2012 |
Hypertonic saline and acute wheezing in preschool children.
Topics: Albuterol; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Length of Stay; Mal | 2012 |
Salmeterol and fluticasone in young children with multiple-trigger wheeze.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Androstadienes; Asthma; | 2012 |
Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing.
Topics: Administration, Inhalation; Albuterol; Anti-Asthmatic Agents; Beclomethasone; Bronchodilator Agents; | 2002 |
Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department.
Topics: Albuterol; Bronchodilator Agents; Child, Preschool; Double-Blind Method; Emergency Service, Hospital | 2003 |
Repeatability of airway resistance measurements made using the interrupter technique.
Topics: Airway Resistance; Albuterol; Bronchial Provocation Tests; Bronchodilator Agents; Child; Child, Pres | 2003 |
Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Asthma; Bone and Bones; Bronchodilator Agents | 2004 |
Comparison of clinical outcome with oral and inhaled bronchodilators in the management of wheezy children aged 1-59 months in the community: a randomised trial in Pakistan.
Topics: Administration, Inhalation; Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Pr | 2004 |
Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
Topics: Aerosols; Airway Resistance; Albuterol; Bronchodilator Agents; Child, Preschool; Double-Blind Method | 2005 |
Responses to inhaled bronchodilators in infancy are not linked with asthma in later childhood.
Topics: Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Child; Child, Preschool; Cross-Over S | 2006 |
Facemasks and aerosol delivery in vivo.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Child, Preschool; Crying; Face; Female; Humans; Infant; | 2007 |
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis.
Topics: Administration, Inhalation; Albuterol; Auscultation; Bronchiolitis, Viral; Diagnosis, Computer-Assis | 2007 |
Dexamethasone and salbutamol in the treatment of acute wheezing in infants.
Topics: Acute Disease; Adrenergic beta-Agonists; Albuterol; Dexamethasone; Double-Blind Method; Drug Therapy | 1983 |
Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children.
Topics: Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Child, Preschool; Double-Blind | 1994 |
Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment of young children with wheezing.
Topics: Administration, Inhalation; Aerosols; Albuterol; Ambulatory Care; Cross-Sectional Studies; Double-Bl | 1994 |
Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Drug Therapy, C | 1996 |
Aminophylline is effective on acute exacerbations of asthma in adults--objective improvements in peak flow, spirogram, arterial blood gas measurements and lung sounds.
Topics: Albuterol; Aminophylline; Blood Gas Analysis; Female; Forced Expiratory Volume; Humans; Male; Middle | 1996 |
Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers.
Topics: Administration, Inhalation; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Humans; Infant; Nebu | 1997 |
Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants.
Topics: Administration, Inhalation; Albuterol; Analysis of Variance; Asthma; Beclomethasone; Bronchodilator | 1997 |
Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Age Factors; Albuterol; Anti-Inflammat | 1997 |
The use of albuterol in hospitalized infants with bronchiolitis.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchiolitis; Bronchodilator Agents; Double-Blind Method; Fema | 1998 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Female; Humans; Infant; Infant, Newborn; Male; Res | 2000 |
Inhaled salbutamol for wheezy infants: a randomised controlled trial.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Metho | 2000 |
Is nebulized aerosol treatment necessary in the pediatric emergency department?
Topics: Administration, Inhalation; Adult; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Chil | 2000 |
The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Child, Preschool; Dose-Response Relati | 1999 |
High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: A double-blind, randomized equivalence trial.
Topics: Acute Disease; Albuterol; Bronchodilator Agents; Child, Preschool; Dose-Response Relationship, Drug; | 2000 |
The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
Topics: Aged; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Double-Blind Method; Dyspnea; Femal | 2000 |
Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis.
Topics: Administration, Inhalation; Albuterol; Bronchiolitis; Bronchodilator Agents; Double-Blind Method; Ep | 2001 |
Salbutamol versus theophylline for wheezy infant.
Topics: Administration, Oral; Albuterol; Female; Humans; Infant; Male; Prospective Studies; Respiratory Soun | 2001 |
Lower arrythmogenic risk of low dose albuterol plus ipratropium.
Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Female; Humans; Infant; Ipratropium; | 2001 |
The use of nebulized albuterol in wheezing infants.
Topics: Albuterol; Double-Blind Method; Emergency Service, Hospital; Female; Heart Rate; Humans; Infant; Inf | 1992 |
Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma.
Topics: Acute Disease; Administration, Intranasal; Albuterol; Asthma; Double-Blind Method; Female; Heart Rat | 1992 |
Effect of nebulized salbutamol in preterm infants during the first year of life.
Topics: Aerosols; Albuterol; Cough; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lu | 1991 |
Effect of salbutamol on specific airway resistance in infants with a history of wheezing.
Topics: Airway Resistance; Albuterol; Carbachol; Child, Preschool; Humans; Infant; Nebulizers and Vaporizers | 1991 |
Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants.
Topics: Aerosols; Albuterol; Dose-Response Relationship, Drug; Double-Blind Method; Equipment Design; Humans | 1991 |
Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol?
Topics: Acute Disease; Albuterol; Bronchiolitis, Viral; Double-Blind Method; Functional Residual Capacity; H | 1991 |
Randomized trial of salbutamol in acute bronchiolitis.
Topics: Acute Disease; Albuterol; Bronchiolitis; Humans; Infant; Nebulizers and Vaporizers; Observer Variati | 1991 |
Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity.
Topics: Albuterol; Heart Rate; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Nebulizers and V | 1991 |
Cough and wheezing from beclomethasone aerosol.
Topics: Aerosols; Albuterol; Asthma; Beclomethasone; Cough; Double-Blind Method; Forced Expiratory Volume; H | 1987 |
79 other studies available for albuterol and Breathing Sounds
| Article | Year |
|---|---|
First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation.
Topics: Albuterol; Bronchoalveolar Lavage; Child; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; | 2022 |
Efficacy of Nebulised Salbutamol with Ipratropium Bromide in Magnesium Sulphate Base in Acute Flare-up of Wheeze among Children Aged 1-12 y.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Humans; Ipratropium; Magnesium | 2023 |
Prehospital management of pediatric asthma patients in a large emergency medical services system.
Topics: Adolescent; Albuterol; Anaphylaxis; Asthma; Child; Emergency Medical Services; Female; Humans; Infus | 2020 |
Air Trapping Correlates With Increased Frequency of Albuterol Use and Severity of Wheeze in Persistent Asthma.
Topics: Albuterol; Asthma; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Male; Metered Do | 2020 |
Prevalence and risk factors for wheeze, decreased forced expiratory volume in 1 s and bronchoconstriction in young children living in Havana, Cuba: a population-based cohort study.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Asthma; Bronchoconstriction; Broncho | 2020 |
Heterogeneity of emergency treatment practices in wheezing preschool children.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Cross-Sectional Studies; Emergency Treat | 2021 |
The Weekday Wheezer.
Topics: Albuterol; Animals; Asthma; Bronchodilator Agents; Child; Diagnosis, Differential; Fluticasone; Guin | 2017 |
Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis.
Topics: Albuterol; Bronchiolitis; Bronchodilator Agents; Emergency Service, Hospital; Female; Hospitalizatio | 2018 |
The impact of nasal aspiration with an automatic device on upper and lower respiratory symptoms in wheezing children: a pilot case-control study.
Topics: Administration, Inhalation; Albuterol; Case-Control Studies; Chi-Square Distribution; Child, Prescho | 2018 |
Chest physiotherapy for acute wheezing: an inappropriate protocol in a misdiagnosed group of patients.
Topics: Albuterol; Ambulatory Care; Bronchodilator Agents; Female; Humans; Male; Physical Therapy Modalities | 2014 |
Chest physiotherapy for acute wheezing episodes: an inappropriate interpretation of the first trial in outpatient infants.
Topics: Albuterol; Ambulatory Care; Bronchodilator Agents; Female; Humans; Male; Physical Therapy Modalities | 2014 |
Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland?
Topics: Acute Disease; Adolescent; Albuterol; Aminophylline; Asthma; Bronchodilator Agents; Child; Child, Pr | 2015 |
Treasure in the chest.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Diagnosis, Differential; Female; Foreign Bodie | 2015 |
Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children.
Topics: Airway Resistance; Albuterol; Anthropometry; Asthma; Bronchodilator Agents; Child; Child, Preschool; | 2016 |
Bronchodilator response in wheezing infants assessed by the raised volume rapid thoracic compression technique.
Topics: Albuterol; Brazil; Bronchodilator Agents; Cross-Sectional Studies; Female; Forced Expiratory Flow Ra | 2016 |
A survey of pediatricians' knowledge on asthma management in children.
Topics: Adrenal Cortex Hormones; Adult; Albuterol; Asthma; Child; Clinical Competence; Epinephrine; Female; | 2008 |
Asthma in the preschool child: still a rose by any other name?
Topics: Acetates; Administration, Inhalation; Albuterol; Bronchodilator Agents; Budesonide; Child, Preschool | 2008 |
Are we adequately managing children with wheeze using the standard case management guidelines?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Bacterial Agents; Asthma; Ausc | 2008 |
A real sugar high? Wheeze and associated hyperglycemia.
Topics: Albuterol; Bronchodilator Agents; Diabetes Mellitus, Type 1; Diagnosis, Differential; Humans; Hydroc | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Assessment and validation of bronchodilation using the interrupter technique in preschool children.
Topics: Airway Resistance; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Child; Child, Preschool; Cough | 2010 |
High exposure to passive tobacco smoking and the development of asthma in an adult patient who had never smoked.
Topics: Albuterol; Asthma; Bronchodilator Agents; Budesonide; Cetirizine; Confined Spaces; Female; Histamine | 2010 |
Lung function in preschool children with a history of wheezing measured by forced oscillation and plethysmographic specific airway resistance.
Topics: Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Humans | 2010 |
Emergency treatment of obstructive bronchitis: change from nebulizers to metered dose inhalers with spacers.
Topics: Age Factors; Albuterol; Bronchitis; Bronchodilator Agents; Child, Preschool; Confidence Intervals; E | 2011 |
Severe allergic reaction to lactulose in a child with milk allergy.
Topics: Albuterol; Anti-Allergic Agents; Cetirizine; Cheese; Child, Preschool; Cough; Humans; Immunoglobulin | 2011 |
Investigating asthma symptoms in primary care.
Topics: Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchodilator Agents; Child; Diagnosis, Diff | 2012 |
Salbutamol with metered dose inhalers with spacers - an established emergency treatment for preschool wheeze.
Topics: Albuterol; Asthma; Bronchitis; Bronchodilator Agents; Child, Preschool; Drug Administration Schedule | 2012 |
Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy.
Topics: Albuterol; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Child; Exercise; Fe | 2013 |
The effect of chemical warfare on respiratory symptoms, pulmonary function tests and their reversibility 23-25 years after exposure.
Topics: Adult; Albuterol; Bronchodilator Agents; Case-Control Studies; Chemical Warfare Agents; Cough; Human | 2015 |
How do we treat wheezing infants? Evidence or anecdote.
Topics: Adrenal Cortex Hormones; Albuterol; Bronchiolitis, Viral; Bronchodilator Agents; Humans; Infant; Ipr | 2002 |
Case 3: presentation. Dyspnoea without wheeze unlikely to be caused by asthma.
Topics: Administration, Inhalation; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; | 2001 |
Bronchodilation in infants with malacia or recurrent wheeze.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Bronchial Diseases; Bronchodilator Agents | 2003 |
Early detection of cardiac disease masquerading as acute bronchospasm: The role of bedside limited echocardiography by the emergency physician.
Topics: Albuterol; Asthma; Bronchial Spasm; Bronchodilator Agents; Calcinosis; Cardiomyopathy, Dilated; Chil | 2003 |
Asthma-like syndrome in a teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Ba | 2003 |
Response to salbutamol by wheezy infants.
Topics: Albuterol; Bronchodilator Agents; Humans; Infant; Respiratory Function Tests; Respiratory Sounds | 2004 |
The response to beta-agonists in wheezy infants: three methods compared.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Forced Expiratory Volume; Humans; Infant | 2004 |
Diagnostic accuracy of bronchodilator responsiveness in wheezy children.
Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Femal | 2005 |
Risk factors of bronchial hyperresponsiveness in children with wheezing-associated respiratory infection.
Topics: Administration, Inhalation; Age Distribution; Albuterol; Bronchial Hyperreactivity; Bronchodilator A | 2005 |
Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene.
Topics: Adolescent; Albuterol; Asthma; Bronchodilator Agents; Chi-Square Distribution; Child; Female; Haplot | 2005 |
Pneumomediastinum and subcutaneous emphysema associated with asthma exacerbation.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Humans; Male; Mediastinal Emphysema; Nebulizers and | 2006 |
[Exercise-induced asthma as perceived by pediatric patients and their parents].
Topics: Administration, Inhalation; Adolescent; Albuterol; Asthma, Exercise-Induced; Bronchial Provocation T | 2006 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response: another piece in the asthma mosaic.
Topics: Albuterol; Asthma; Bronchodilator Agents; Forced Expiratory Volume; Humans; Nebulizers and Vaporizer | 2007 |
Metabolic acidosis in severe asthma: Is it the disease or is it the doctor?
Topics: Acidosis; Acute Disease; Albuterol; Asthma; Blood Gas Analysis; Bronchodilator Agents; Child, Presch | 2007 |
Exercise-induced asthma in Nepalese children.
Topics: Adolescent; Albuterol; Asthma; Asthma, Exercise-Induced; Child; Child, Preschool; Exercise Test; Fem | 1981 |
Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age.
Topics: Albuterol; Asthma; Blood Proteins; Bronchial Provocation Tests; Bronchodilator Agents; Case-Control | 1995 |
Predictors of bronchodilator responsiveness in infants with wheezing associated respiratory tract infection.
Topics: Albuterol; Female; Humans; Infant; Male; Respiratory Sounds; Respiratory Tract Infections; Treatment | 1994 |
An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Analysis of Variance; | 1995 |
Albuterol administered by metered-dose inhaler and spacer to young children with wheezing.
Topics: Administration, Inhalation; Albuterol; Child, Preschool; Humans; Infant; Nebulizers and Vaporizers; | 1994 |
Nonspecific refractoriness to adenylyl cyclase stimulation in alveolar macrophages from infants with recurrent bronchiolitis.
Topics: Adenylyl Cyclases; Albuterol; Asthma; Bronchiolitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; Col | 1994 |
Salbutamol and moaning.
Topics: Albuterol; Basal Ganglia; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neurologic Ex | 1994 |
Variable response to bronchodilator therapy in young children born prematurely.
Topics: Aerosols; Airway Resistance; Albuterol; Child, Preschool; Female; Humans; Infant; Infant, Newborn; I | 1993 |
Changes in frequency spectra of breath sounds during histamine challenge test in adult asthmatics and healthy control subjects.
Topics: Adolescent; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Female; Forc | 1994 |
Bronchodilators in infancy.
Topics: Airway Obstruction; Albuterol; Child, Preschool; Humans; Infant; Infant, Newborn; Respiratory Sounds | 1993 |
Ventilatory function in British adults after asthma or wheezing illness at ages 0-35.
Topics: Adolescent; Adult; Age of Onset; Albuterol; Asthma; Bronchitis; Bronchodilator Agents; Child; Child, | 1996 |
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Topics: Adrenergic beta-Agonists; Albuterol; Alleles; Arginine; Asthma; Bronchodilator Agents; Child; Glutam | 1997 |
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Topics: Adrenergic beta-Agonists; Albuterol; Alleles; Arginine; Asthma; Bronchodilator Agents; Child; Glutam | 1997 |
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Topics: Adrenergic beta-Agonists; Albuterol; Alleles; Arginine; Asthma; Bronchodilator Agents; Child; Glutam | 1997 |
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Topics: Adrenergic beta-Agonists; Albuterol; Alleles; Arginine; Asthma; Bronchodilator Agents; Child; Glutam | 1997 |
Effect of pneumonia and whooping cough in childhood on adult lung function.
Topics: Adult; Albuterol; Asthma; Child; Child, Preschool; Cohort Studies; Female; Forced Expiratory Volume; | 1998 |
Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report.
Topics: Albuterol; Antiviral Agents; Asthma; Bronchial Hyperreactivity; Bronchiolitis; Bronchodilator Agents | 1998 |
Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants.
Topics: Albuterol; Bronchi; Bronchodilator Agents; Child; Female; Forced Expiratory Flow Rates; Humans; Lung | 1998 |
Prevalence of asthma and respiratory symptoms in dairy farmers in the French province of the Doubs.
Topics: Adult; Age Factors; Albuterol; Allergens; Asthma; Bronchitis; Bronchodilator Agents; Chronic Disease | 1998 |
Airway and tissue resistance in wheezy infants: effects of albuterol.
Topics: Administration, Inhalation; Airway Resistance; Albuterol; Bronchodilator Agents; Female; Humans; Inf | 1999 |
Modulation of airway caliber by deep inhalation in children.
Topics: Airway Resistance; Albuterol; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; | 2000 |
Dispensing home nebulizers for acute wheezing from the hospital is cost-effective.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilat | 2000 |
Airway resistance and atopy in preschool children with wheeze and cough.
Topics: Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Cough; Female; Humans | 2000 |
Limitations in the use of median frequency for lung sound analysis.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Case-Control Studies; Child; Chil | 2000 |
Bronchodilator responsiveness and atopy in 5-10-yr-old coughers.
Topics: Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Cough; Cross-S | 2001 |
Do clinical variables predict pathologic radiographs in the first episode of wheezing?
Topics: Adolescent; Albuterol; Bronchodilator Agents; Child; Child, Preschool; Discriminant Analysis; Female | 2002 |
Pulse oximetry and peak flow as indicators of wheezing severity in children and improvement following bronchodilator treatments.
Topics: Adolescent; Adult; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Child; Emergency Service, Hos | 1992 |
The prehospital use of nebulized albuterol on patients with wheezing whose chief complaint is shortness of breath.
Topics: Adult; Aged; Albuterol; Asthma; Child; Child, Preschool; Emergency Medical Services; Female; Humans; | 1992 |
Respirosonography in infants with acute bronchiolitis.
Topics: Acoustics; Acute Disease; Albuterol; Bronchiolitis; Diagnosis, Computer-Assisted; Female; Humans; In | 1991 |
The severity of asthma in relation to beta agonist prescribing.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Chronic Dise | 1991 |
[Wheezing dyspnea].
Topics: Albuterol; Child; Dyspnea; Humans; Male; Respiratory Sounds; Theophylline | 1990 |
Asthma in the very young baby.
Topics: Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Humans; Infant; Nebulizers and Vaporizer | 1989 |
Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors.
Topics: Albuterol; Bronchi; Dose-Response Relationship, Drug; Drug Interactions; Functional Residual Capacit | 1987 |
Hypoxaemia in wheezy infants after bronchodilator treatment.
Topics: Albuterol; Carbon Dioxide; Humans; Hypoxia; Infant; Oxygen; Partial Pressure; Recurrence; Respirator | 1987 |
Trachea-noise biofeedback in asthma: a comparison of the effect of trachea-noise biofeedback, a bronchodilator, and no treatment on the rate of recovery from exercise- and eucapnic hyperventilation-induced asthma.
Topics: Adult; Albuterol; Asthma; Asthma, Exercise-Induced; Biofeedback, Psychology; Bronchial Spasm; Double | 1988 |
Nebulised salbutamol does have a protective effect on airways in children under 1 year old.
Topics: Airway Resistance; Albuterol; Bronchi; Bronchial Provocation Tests; Female; Humans; Infant, Newborn; | 1988 |
Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.
Topics: Airway Resistance; Albuterol; Humans; Infant; Lung; Nebulizers and Vaporizers; Peak Expiratory Flow | 1987 |